Business Context and Reporting Period
This Form 8-K Current Report was filed by MIMEDX GROUP, INC. on January 15, 2010. The report discloses significant changes in the company's executive leadership, specifically the departure of the Chief Financial Officer and the appointment of a successor effective on the same date.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel changes and compensation arrangements.
Material Changes
- Departure: Michael J. Culumber's employment as Chief Financial Officer terminated effective January 15, 2010.
- Appointment: Michael J. Senken was appointed Chief Financial Officer effective January 15, 2010.
Compensation and Management Commentary
The Board of Directors established the following compensation package for the new CFO, Michael J. Senken:
- Base Salary: $170,000 annually.
- Bonus: Eligible for an annual target bonus equal to 30% of base salary, subject to the approval of an incentive plan by the Compensation Committee.
- Stock Options: Granted options to purchase 150,000 shares of Common Stock. Vesting occurs in three equal tranches (one-third) on each anniversary of the grant date, contingent on continued employment.
- Contingent Grant: If the Board amends the 2006 Assumed Stock Incentive Plan to increase available shares by at least 100,000 (subject to shareholder approval), Mr. Senken will receive an additional 100,000 options with identical vesting terms.
Mr. Senken brings prior experience as CFO for Park 'N Fly, Inc. and Patient Portal Technologies, and held senior executive roles at Philips Consumer Electronics and Philips Broadband Networks.
Investor Verification Checklist
- Verify the effective date of Michael J. Culumber's departure and the transition of duties.
- Confirm the status of the 2006 Assumed Stock Incentive Plan amendment required to trigger the additional 100,000 stock options.
- Review the specific terms of the executive incentive plan to be approved by the Compensation Committee.
- Check for any subsequent filings regarding the vesting schedule or exercise of the granted options.